Cefpirome

Welcome to Dwaey, specifically on Cefpirome page.
This medicine contains important and useful components, as it consists of
Cefpirome is available in the market in concentration.

Generic Name of Cefpirome - Learn More

Cefpirome

Cefpirome Precaution - What You Need to Know

- Special Populations: Cefpirome is a fourth-generation cephalosporin antibiotic, typically classified as a pregnancy category B drug, meaning animal studies have not shown harm to the fetus, but there are no well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefits outweigh the risks. Cefpirome is excreted into breast milk in small amounts; therefore, caution is advised when administering it to breastfeeding mothers, particularly in neonates and infants. Special care should be taken in elderly patients or those with existing renal impairment.
- Renal Impairment: Cefpirome is primarily eliminated through the kidneys. Therefore, dose adjustments are necessary for patients with impaired renal function. In patients with creatinine clearance (CrCl) below 50 mL/min, the dose or frequency should be adjusted to prevent drug accumulation and minimize the risk of toxicity.
- Monitoring Parameters: Patients on Cefpirome therapy, especially those with renal impairment or undergoing prolonged treatment, should have their renal function regularly monitored. Blood tests should be conducted to assess liver function, and monitoring of blood counts is essential, particularly for prolonged courses of therapy. Observation for allergic reactions, such as skin rashes or anaphylaxis, should also be conducted.
- Misuse or Dependency: Cefpirome does not carry a risk of misuse or dependency. However, misuse of antibiotics, including Cefpirome, can lead to antibiotic resistance. It's crucial for patients to complete the entire prescribed course, even if they feel better, to prevent the development of resistant bacterial strains.

Cefpirome Indication - Uses and Benefits

- Primary Indications: Cefpirome is used for the treatment of serious infections caused by susceptible organisms. It is indicated for:
- Hospital-acquired pneumonia.
- Complicated urinary tract infections (e.g., pyelonephritis).
- Complicated skin and soft tissue infections.
- Intra-abdominal infections.
- Sepsis (bacteremia).
- Evidence-Based Context: Cefpirome is a broad-spectrum antibiotic effective against both Gram-positive and Gram-negative bacteria. It is particularly potent against Gram-negative pathogens such as *Pseudomonas aeruginosa* and *Enterobacter* species, which are often resistant to other antibiotics. Its use is generally reserved for more severe or resistant infections where broad-spectrum coverage is needed, particularly in hospitalized patients or those with immunocompromised conditions.
- Off-label Uses: Although Cefpirome is primarily used for the indications listed above, it may also be used off-label for treating infections caused by multidrug-resistant organisms in certain cases, depending on local susceptibility patterns and clinical judgment.

Cefpirome Contraindications - Important Warnings

- Exclusion Criteria: Cefpirome is contraindicated in individuals with known hypersensitivity to cephalosporins or penicillins due to the risk of severe allergic reactions such as anaphylaxis or angioedema. It should also be avoided in patients with a history of severe allergic reactions to beta-lactam antibiotics.
- Rationale: The primary contraindication is related to the risk of severe hypersensitivity reactions, especially anaphylactic shock, which may be life-threatening. Patients who have a history of such reactions to beta-lactam antibiotics are at high risk for cross-reactivity and should avoid Cefpirome.
- Age and Demographic Considerations: Cefpirome is not recommended for neonates or young infants due to limited safety data. Additionally, dose adjustments are necessary for elderly patients and those with renal impairment, as they may be more prone to drug accumulation and potential toxic effects.

Cefpirome Side Effects - What to Expect

- Common Side Effects: The most frequently reported side effects of Cefpirome are gastrointestinal disturbances, including nausea, vomiting, diarrhea, and abdominal pain. Patients may also experience mild pain or swelling at the injection site.
- Serious Side Effects: Severe reactions, though rare, can include:
- Hypersensitivity reactions: Anaphylaxis, urticaria, angioedema, or fever.
- Hematologic abnormalities: Thrombocytopenia (low platelet count), neutropenia (low white blood cell count), or hemolytic anemia.
- Clostridium difficile-associated diarrhea (CDAD): This potentially life-threatening condition is a risk with prolonged use of broad-spectrum antibiotics, including Cefpirome.
- Neurotoxic effects: High doses or renal impairment may lead to neurotoxicity, including confusion, seizures, or encephalopathy.
- Mitigation and Monitoring: To minimize gastrointestinal side effects, Cefpirome should be administered with food. If allergic reactions, blood count abnormalities, or gastrointestinal disturbances occur, the drug should be discontinued, and appropriate medical attention should be sought. Regular monitoring of renal function and blood counts is advised for patients receiving prolonged therapy or those with pre-existing renal dysfunction.

Cefpirome Mode of Action - How It Works

- Mechanism: Cefpirome is a cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis. It binds to and inactivates penicillin-binding proteins (PBPs), which are essential for the final stages of peptidoglycan synthesis in bacterial cell walls. This inhibition weakens the bacterial cell wall, causing the bacteria to lyse and die.
- Pharmacodynamics and Pharmacokinetics: Cefpirome is bactericidal, meaning it kills bacteria rather than merely inhibiting their growth. After intravenous or intramuscular administration, Cefpirome reaches peak plasma concentrations within 30 minutes to 1 hour. The drug has a half-life of approximately 2 hours and is primarily excreted unchanged by the kidneys. Cefpirome has a broad spectrum of activity, particularly against Gram-negative bacteria, including *Pseudomonas aeruginosa*, which makes it effective for treating infections caused by multi-drug-resistant organisms.
- Distinctive Action: The advantage of Cefpirome over earlier-generation cephalosporins is its improved activity against Gram-negative bacteria, particularly those resistant to first and second-generation agents. Its spectrum includes both aerobic and anaerobic organisms, making it useful for treating mixed infections in hospitalized patients.

Cefpirome Drug Interactions - What to Avoid

- Drug-Drug Interactions: Cefpirome may interact with other medications, including:
- Aminoglycosides (e.g., gentamicin): The combination of Cefpirome and aminoglycosides can increase the risk of nephrotoxicity, so close monitoring of renal function is essential.
- Probenecid: Co-administration of probenecid can inhibit the renal excretion of Cefpirome, leading to increased serum levels and a potential risk of toxicity.
- Oral anticoagulants (e.g., warfarin): Cefpirome may enhance the effect of oral anticoagulants, increasing the risk of bleeding. Close monitoring of coagulation parameters is recommended when using these drugs together.
- Food and Alcohol Interactions: Cefpirome can be taken with or without food. There are no major interactions with food or alcohol; however, excessive alcohol consumption should be avoided during any antibiotic treatment due to potential gastrointestinal discomfort.
- Clinical Recommendations: When combining Cefpirome with aminoglycosides or probenecid, it is crucial to monitor kidney function to avoid nephrotoxicity. The bleeding risk with anticoagulants should be monitored closely. Doses may need to be adjusted for individuals with renal dysfunction.

Cefpirome Adult Dose - Recommended Dosage

- Standard Dosage: For most infections, the usual adult dose of Cefpirome is 1 to 2 grams every 12 hours, depending on the severity and type of infection. In more severe infections, such as sepsis, the dose may be increased to 2 grams every 8 to 12 hours.
- Administration: Cefpirome is administered intravenously or intramuscularly. If given intravenously, it should be administered slowly over 3-5 minutes.
- Maximum Dosage: The maximum recommended dose for Cefpirome is typically 12 grams per day, divided into 2 to 4 doses, depending on the severity of the infection.

Cefpirome Child Dose - Dosage for Children

- Pediatric Dosing: The usual dose of Cefpirome for pediatric patients is 30 to 50 mg/kg/day, divided into 2 to 3 doses. The maximum daily dose for children should not exceed 12 grams per day.
- Safety and Efficacy: Cefpirome can be safely used in children for severe infections, but the dose should be adjusted based on the child's weight and renal function. The safety profile in pediatric patients is similar to that in adults, though close monitoring for allergic reactions and renal function is recommended.
- Pediatric Monitoring: Regular monitoring of blood counts, renal function, and signs of adverse reactions should be performed during Cefpirome treatment in children, especially if the therapy is prolonged. Dose adjustments may be necessary for those with renal impairment.

Cefpirome Renal Dose - Dosage for Kidney Conditions

- Renal Impairment: For patients with renal dysfunction, the dosing of Cefpirome should be adjusted as follows:
- CrCl 10-50 mL/min: 1 to 2 grams every 12 hours.
- CrCl <10 mL/min: 1 to 2 grams every 24 hours.
- Monitoring Recommendations: Regular monitoring of renal function is essential in patients with renal impairment to avoid drug accumulation and toxicity. In cases of renal failure, further dose adjustments may be required.